196 related articles for article (PubMed ID: 11015384)
1. Comparison of phenotypic and genotypic methods for pyrazinamide susceptibility testing with Mycobacterium tuberculosis.
Davies AP; Billington OJ; McHugh TD; Mitchison DA; Gillespie SH
J Clin Microbiol; 2000 Oct; 38(10):3686-8. PubMed ID: 11015384
[TBL] [Abstract][Full Text] [Related]
2. Surveillance of pyrazinamide susceptibility among multidrug-resistant Mycobacterium tuberculosis isolates from Siriraj Hospital, Thailand.
Jonmalung J; Prammananan T; Leechawengwongs M; Chaiprasert A
BMC Microbiol; 2010 Aug; 10():223. PubMed ID: 20727143
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic and genotypic characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis clinical isolates in Hangzhou, China.
Liu W; Chen J; Shen Y; Jin J; Wu J; Sun F; Wu Y; Xie L; Zhang Y; Zhang W
Clin Microbiol Infect; 2018 Sep; 24(9):1016.e1-1016.e5. PubMed ID: 29288021
[TBL] [Abstract][Full Text] [Related]
4. Pyrazinamide resistance and mutations in pncA among isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, Pakistan.
Khan MT; Malik SI; Ali S; Masood N; Nadeem T; Khan AS; Afzal MT
BMC Infect Dis; 2019 Feb; 19(1):116. PubMed ID: 30728001
[TBL] [Abstract][Full Text] [Related]
5. Direct Detection of Pyrazinamide Resistance in Mycobacterium tuberculosis by Use of
Tam KK; Leung KS; Siu GK; Chang KC; Wong SS; Ho PL; Leung EK; Yam WC
J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31189582
[TBL] [Abstract][Full Text] [Related]
6. Genotypic characterization of pyrazinamide resistance in Mycobacterium tuberculosis isolated from Lusaka, Zambia.
Bwalya P; Yamaguchi T; Mulundu G; Nakajima C; Mbulo G; Solo ES; Fukushima Y; Kasakwa K; Suzuki Y
Tuberculosis (Edinb); 2018 Mar; 109():117-122. PubMed ID: 29559115
[TBL] [Abstract][Full Text] [Related]
7. Discrepant results between pyrazinamide susceptibility testing by the reference BACTEC 460TB method and pncA DNA sequencing in patients infected with multidrug-resistant W-Beijing Mycobacterium tuberculosis strains.
Dormandy J; Somoskovi A; Kreiswirth BN; Driscoll JR; Ashkin D; Salfinger M
Chest; 2007 Feb; 131(2):497-501. PubMed ID: 17296653
[TBL] [Abstract][Full Text] [Related]
8. [Studies on pncA gene mutations in M. tuberculosis isolates].
Wu X; Zhang J; Zhong M
Zhonghua Jie He He Hu Xi Za Zhi; 2000 Jan; 23(1):40-2. PubMed ID: 11778181
[TBL] [Abstract][Full Text] [Related]
9. Comparison of phenotypic and genotypic methods for pyrazinamide susceptibility testing.
Shenai S; Rodrigues C; Sadani M; Sukhadia N; Mehta A
Indian J Tuberc; 2009 Apr; 56(2):82-90. PubMed ID: 19810590
[TBL] [Abstract][Full Text] [Related]
10. pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis isolates from northwestern Russia.
Marttila HJ; Marjamäki M; Vyshnevskaya E; Vyshnevskiy BI; Otten TF; Vasilyef AV; Viljanen MK
Antimicrob Agents Chemother; 1999 Jul; 43(7):1764-6. PubMed ID: 10390239
[TBL] [Abstract][Full Text] [Related]
11. Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis.
Scorpio A; Lindholm-Levy P; Heifets L; Gilman R; Siddiqi S; Cynamon M; Zhang Y
Antimicrob Agents Chemother; 1997 Mar; 41(3):540-3. PubMed ID: 9055989
[TBL] [Abstract][Full Text] [Related]
12. Pyrazinoic acid efflux rate in Mycobacterium tuberculosis is a better proxy of pyrazinamide resistance.
Zimic M; Fuentes P; Gilman RH; Gutiérrez AH; Kirwan D; Sheen P
Tuberculosis (Edinb); 2012 Jan; 92(1):84-91. PubMed ID: 22004792
[TBL] [Abstract][Full Text] [Related]
13. Association between pncA gene mutations, pyrazinamidase activity, and pyrazinamide susceptibility testing in Mycobacterium tuberculosis.
Aono A; Chikamatsu K; Yamada H; Kato T; Mitarai S
Antimicrob Agents Chemother; 2014 Aug; 58(8):4928-30. PubMed ID: 24867972
[TBL] [Abstract][Full Text] [Related]
14. Reevaluation of the critical concentration for drug susceptibility testing of Mycobacterium tuberculosis against pyrazinamide using wild-type MIC distributions and pncA gene sequencing.
Werngren J; Sturegård E; Juréen P; Ängeby K; Hoffner S; Schön T
Antimicrob Agents Chemother; 2012 Mar; 56(3):1253-7. PubMed ID: 22203587
[TBL] [Abstract][Full Text] [Related]
15. Pyrazinamide resistance-conferring mutations in pncA and the transmission of multidrug resistant TB in Georgia.
Sengstake S; Bergval IL; Schuitema AR; de Beer JL; Phelan J; de Zwaan R; Clark TG; van Soolingen D; Anthony RM
BMC Infect Dis; 2017 Jul; 17(1):491. PubMed ID: 28697808
[TBL] [Abstract][Full Text] [Related]
16. Improved Detection by Next-Generation Sequencing of Pyrazinamide Resistance in Mycobacterium tuberculosis Isolates.
Maningi NE; Daum LT; Rodriguez JD; Mphahlele M; Peters RP; Fischer GW; Chambers JP; Fourie PB
J Clin Microbiol; 2015 Dec; 53(12):3779-83. PubMed ID: 26378284
[TBL] [Abstract][Full Text] [Related]
17. Non-
Werngren J; Alm E; Mansjö M
J Clin Microbiol; 2017 Jun; 55(6):1920-1927. PubMed ID: 28404681
[TBL] [Abstract][Full Text] [Related]
18. Correlation of pncA sequence with pyrazinamide resistance level in BACTEC for 21 mycobacterium tuberculosis clinical isolates.
Mestdagh M; Realini L; Fonteyne PA; Rossau R; Jannes G; Mijs W; DE Smet KA; Portaels F; Van den Eeckhout E
Microb Drug Resist; 2000; 6(4):283-7. PubMed ID: 11272256
[TBL] [Abstract][Full Text] [Related]
19. Pyrazinamide susceptibility testing in Mycobacterium tuberculosis: a systematic review with meta-analyses.
Chang KC; Yew WW; Zhang Y
Antimicrob Agents Chemother; 2011 Oct; 55(10):4499-505. PubMed ID: 21768515
[TBL] [Abstract][Full Text] [Related]
20. Effect of pyrazinamidase activity on pyrazinamide resistance in Mycobacterium tuberculosis.
Sheen P; Ferrer P; Gilman RH; López-Llano J; Fuentes P; Valencia E; Zimic MJ
Tuberculosis (Edinb); 2009 Mar; 89(2):109-13. PubMed ID: 19249243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
